Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Non-Current Deffered Revenue (2016 - 2022)

Sonoma Pharmaceuticals (SNOA) has 2 years of Non-Current Deffered Revenue data on record, last reported at $3.0 million in Q4 2012.

  • For Q4 2012, Non-Current Deffered Revenue rose 2028.57% year-over-year to $3.0 million; the TTM value through Dec 2012 reached $3.0 million, up 2028.57%, while the annual FY2012 figure was $133000.0, 16.87% down from the prior year.
  • Non-Current Deffered Revenue reached $3.0 million in Q4 2012 per SNOA's latest filing, down from $3.4 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $3.4 million in Q3 2012 and bottomed at $126000.0 in Q2 2012.